Needham & Company Cuts Price target on Radware Ltd. (RDWR) to $18 Following 14c EPS Miss

Go back to Needham & Company Cuts Price target on Radware Ltd. (RDWR) to $18 Following 14c EPS Miss

Imperial Capital Cuts Price Target on Radware Ltd. (RDWR) Following Preliminary 3Q Results

October 7, 2015 1:37 PM EDT

Imperial Capital maintained an Outperform rating on Radware (NASDAQ: RDWR), and cut the price target to $18.00 (from $25.00), following the company's preliminary 3Q15 results. Results were significantly below consensus estimates due to the delayed closings of several large transactions, primarily in the U.S. carrier and service... More

Buckingham Research Downgrades Radware (RDWR) to Neutral

October 7, 2015 8:53 AM EDT

Buckingham Research downgraded Radware (NASDAQ: RDWR) from Buy to Neutral.

For an analyst ratings summary and ratings history on Radware click here. For more ratings news on Radware click here.

Shares of Radware closed at $14.01 yesterday.

... More

Wells Fargo Downgrades Radware (RDWR) to Market Perform

October 6, 2015 12:55 PM EDT

Wells Fargo downgraded Radware (NASDAQ: RDWR) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Radware click here. For more ratings news on Radware click here.

Shares of Radware closed at $17.32 yesterday.

... More

Unusual 11 Mid-Day Movers 10/6: (PMCS) (BTU) (ACI) Higher; (EXAS) (RDWR) (TCS) Lower

October 6, 2015 12:49 PM EDT

Exact Sciences (Nasdaq: EXAS) 43.9% LOWER; issued the following statement following the U.S. Preventive Services Task Force (USPSTF) draft recommendation statement for colorectal cancer screening. USPSTF included Cologuard in the draft guidelines as an alternative screening test, along with CT colonography. The draft guidelines recommend an A rating for colorectal cancer screening starting at age 50 and continuing until age 75. Screening for individuals age 75 through 85 is graded a C. This approach represents a change from the 2008 recommendations, which assigned specific grades for different tests, including an I rating for stool-based DNA.

PMC-Sierra, Inc.... More

UPDATE: Oppenheimer Downgrades Radware (RDWR) to Perform

October 6, 2015 7:43 AM EDT

(Updated - October 6, 2015 9:57 AM EDT)

Oppenheimer downgraded Radware (NASDAQ: RDWR) from Outperform to Perform and removed its price target (prior $23.00). The change follows the company's negative pre-announcement.

Commenting on Radware's Q3 shortfall, analyst Ittai Kidron said, "The company offered... More

Radware Ltd. (RDWR) Prelim. Q3 Revenue, EPS Results Miss Views

October 5, 2015 5:02 PM EDT

Radware Ltd. (NASDAQ: RDWR) announced preliminary results for the third quarter of 2015. Revenues for the quarter are expected to be $48 million, below the companys guidance of $57 million to $59 million. Non-GAAP EPS is expected to be $0.10 per diluted share, compared to guidance of $0.23 to... More